Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Andrew L, Pecora"'
Autor:
Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy
Publikováno v:
Blood. 140:11893-11895
Autor:
Maher Albitar, Andrew Ip, Andre H. Goy, Katherine Linder, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Andrew L. Pecora, Jamie Koprivnikar, James McCloskey
Publikováno v:
Blood. 140:6270-6271
Autor:
Rena Feinman, Ariel A. Aptekmann, Iriana Colorado, Samuel Roy, Joshua Zenreich, Sophia H. Dar, Adolfo Aleman, Rashmi Unawane, Margaret Zhuang, Megan Korkoleo, Mariefel Vendivil, Andrea Ricourt, Andrew McConnell, Phyllis McKiernan, Anqi Dai, Andrew L. Pecora, Noa Biran, David Siegel, Jonathan U. Peled, Michele L. Donato
Publikováno v:
Blood. 140:4843-4844
Autor:
Maher Albitar, Hong Zhang, Andrew Ip, Jeffrey Justin Estella, Ahmad Charifa, Wanlong Ma, Ipsa Sharma, Andrew L. Pecora, Lori Leslie, Tatyana Feldman, Andre H. Goy
Publikováno v:
Blood. 140:7828-7829
Autor:
Maher Albitar, Hong Zhang, Andrew L. Pecora, Andrew Ip, Andre H. Goy, Spiraggelos Antzoulatos, Wanlong Ma, Sukhdeep Kaur, Hyung C. Suh, Michele L. Donato, Scott D. Rowley
Publikováno v:
Blood. 140:4757-4758
Autor:
Andre Goy, Hong Zhang, Andrew Ip, Ivan De Dios, Jeffrey Estella, Tatyana Feldman, Andrew L. Pecora, Maher Albitar, Wanlong Ma, Lori A. Leslie
Publikováno v:
Blood. 138:4480-4480
Introduction: Liquid biopsy has been reported to be useful in predicting residual disease in patients with diffuse large B-cell lymphoma (DLBCL). Most of the studies focused on quantifying the level of circulating lymphoma-specific DNA. We explored t
Autor:
Andrew Ip, Andre Goy, Scott D. Rowley, Hong Zhang, Andrew L. Pecora, Ivan De Dios, Hyung C. Suh, Sukhdeep Kaur, Michele L. Donato, Wanlong Ma, Maher Albitar, Spiraggelos Antzoulatos
Publikováno v:
Blood. 138:2892-2892
Introduction: Acute graft-vs.-host disease (aGVHD) remains a major diagnostic and clinical problem in patients after allogenic hematopoietic stem cell transplant (HSCT). Finding biomarkers that play a role in aGVHD not only helps in predicting and di
Autor:
Andrew Ip, Ivan De Dios, Sukhdeep Kaur, Hyung C. Suh, Andre Goy, Scott D. Rowley, Jeffrey Estella, Andrew L. Pecora, Maher Albitar, Michele L. Donato, Hong Zhang, Wanlong Ma
Publikováno v:
Blood. 138:1828-1828
Introduction: Using next generation sequencing (NGS) in monitoring residual disease in patients with myeloid neoplasms is complicated by the significant heterogeneity in these diseases and the frequent presence of CHIP (clonal hematopoiesis of indete
Autor:
Andre Goy, Jeffrey Estella, James K. McCloskey, Andrew Ip, Jamie Koprivnikar, Andrew L. Pecora, Ivan De Dios, Wanlong Ma, Maher Albitar
Publikováno v:
Blood. 138:3463-3463
Introduction: Cytogenetic analysis is important for stratifying patients with various myeloid neoplasms. It has been reported that whole-genome sequencing can be used as an alternative to cytogenetic analysis in acute myeloid leukemia (AML) and myelo
Autor:
Michele Donato, Scott D. Rowley, Pashna N. Munshi, Ronit Reich-Slotky, Noa Biran, Stuart L. Goldberg, Sarah Makhani, David S. Siegel, David H. Vesole, Andrew L. Pecora
Publikováno v:
Blood. 134:4475-4475
Background: Salvage autologous hematopoietic stem cell transplantation (HSCT) is an effective treatment for patients with relapsed multiple myeloma (MM). Adequate HPSC after multiple cycles of dose-intense melphalan (mel) can be harvested, cryopreser